5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde丨CAS 231278-84-5

5-[4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl]-2-furaldehyde is a highly functionalized small molecule primarily used in pharmaceutical research and medicinal chemistry. It serves as a key intermediate in the development of kinase inhibitors and other targeted therapeutic compounds, where the quinazoline core provides a scaffold for receptor and enzyme interaction. The molecule is applied in structure–activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties of drug candidates. Its furaldehyde and substituted phenyl groups allow further chemical modifications, enabling exploration of diverse derivatives in drug discovery programs. In addition, this compound is used in preclinical research for enzyme inhibition assays, receptor binding studies, and mechanistic investigations of signal transduction pathways relevant to cancer and other proliferative diseases.

The benefits of this compound arise from its multifunctional structure, synthetic versatility, and suitability for precision medicinal chemistry. The quinazoline core provides strong receptor-binding potential, while the chloro, fluoro, and furan aldehyde substituents allow targeted chemical modifications to enhance bioactivity and selectivity. Its well-defined molecular structure supports reproducible synthesis, high-purity isolation, and reliable incorporation into multi-step synthetic pathways. The molecule's functional groups enable diverse reactions, including condensation, nucleophilic substitution, and coupling, facilitating rapid analog generation for SAR optimization. Its compatibility with standard organic solvents and laboratory conditions ensures ease of handling in research and development settings.